National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2013 (No. 5) (No. PB 31 of 2013) (Cth)
PB 31 of 2013
National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2013 (No. 5)
National Health Act 1953
___________________________________________________________________________
I, Kim Bessell, Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this instrument under subsections 100(1) and (2) of the National Health Act 1953.
Dated 21 May 2013
KIM BESSELL
Assistant Secretary
Pharmaceutical Access Branch
Principal Pharmacy Advisor
Pharmaceutical Benefits Division
Department of Health and Ageing
___________________________________________________________________
1 Name of Instrument
(1)This Instrument is the National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2013 (No.5).
(2)This Instrument may also be cited as PB 31 of 2013.
2 Commencement
This Instrument commences on 1 June 2013.
3 Amendments to PB 79 of 2011
Schedule 1 amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011).
Schedule 1 Amendments
Schedule 1 Part 1, entry for Carboplatin in the form Solution for I.V. injection 150 mg in 15 mL with manner of administration Injection and brand Carboplatin Ebewe:
substitute:
Solution for I.V. injection 150 mg in 15 mL Injection Carbaccord
Carboplatin Ebewe
WQ
SZ
MP
MP
D
D
Schedule 1 Part 1, entry for Carboplatin in the form Solution for I.V. injection 450 mg in 45 mL with manner of administration Injection and brand Carboplatin Ebewe:
substitute:
Solution for I.V. injection 450 mg in 45 mL Injection Carbaccord
Carboplatin Ebewe
WQ
SZ
MP
MP
D
D
Schedule 1 Part 1, entry for Carboplatin in the form Solution for I.V. injection 50 mg in 5 mL with manner of administration Injection and brand Carboplatin Ebewe:
substitute:
Solution for I.V. injection 50 mg in 5 mL Injection Carbaccord
Carboplatin Ebewe
WQ
SZ
MP
MP
D
D
Schedule 1 Part 1, entry for Gemcitabine in the form Powder for I.V. infusion 1 g (as hydrochloride) with manner of administration Injection and brand Gemcitabine Actavis:
omit from the column headed “Responsible Person” : TA
substitute: WQ
Schedule 1 Part 1, after the entry for Gemcitabine in the form Powder for I.V infusion 2 g (as hydrochloride) with manner of administration Injection and brand DBL Gemcitabine for injection:
insert:
Gemcitabine Actavis 2000 WQ MP D
Schedule 1 Part 1, entry for Gemcitabine in the form Powder for I.V. infusion 200 mg (as hydrochloride) with manner of administration Injection and brand Gemcitabine Actavis:
omit from the column headed “Responsible Person” : TA
substitute: WQ
Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.
See
0
0
0